Skip to main content
logo
Guardant Health, Inc. (GH)
NASDAQ: GH · Real-Time Price · USD
106.89
-0.68 (-0.63%)
At close: Jan 13, 2026, 4:00 PM EST
105.01
-1.88 (-1.76%)
After-hours: Jan 13, 2026, 6:38 PM EST

Guardant Health Revenue

Guardant Health had revenue of $265.20M in the quarter ending September 30, 2025, with 38.50% growth. This brings the company's revenue in the last twelve months to $902.57M, up 30.38% year-over-year. In the year 2024, Guardant Health had annual revenue of $739.02M with 31.04% growth.

Revenue (ttm)
$902.57M
Revenue Growth
+30.38%
P/S Ratio
14.70
Revenue / Employee
$446,595
Employees
2,021
Market Cap
13.77B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024739.02M175.07M31.04%
Dec 31, 2023563.95M114.41M25.45%
Dec 31, 2022449.54M75.89M20.31%
Dec 31, 2021373.65M86.92M30.32%
Dec 31, 2020286.73M72.36M33.75%
Dec 31, 2019214.38M123.74M136.52%
Dec 31, 201890.64M40.80M81.85%
Dec 31, 201749.84M24.59M97.40%
Dec 31, 201625.25M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

GH News

More News